Atelvia 30.1 mg/1 (Risedronate Sodium TABLET, DELAYED RELEASE) 30.1 mg/1

Atelvia 30.1 mg is a delayed-release tablet containing risedronate sodium, used to support bone health. This medication is commonly prescribed for conditions related to bone density and strength.

Strength

30.1 mg/1

Pack Size

4 TABLET, DELAYED RELEASE in 1 DOSE PACK (0430-0979-03)

Manufacturer / TM Owner

Allergan, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Atelvia 30.1 mg is primarily used to treat conditions associated with bone loss, such as osteoporosis. Risedronate sodium, the active ingredient, helps to maintain bone density and reduce the risk of fractures. This medication is often recommended for individuals who are at risk of bone-related issues, including postmenopausal women. What is Atelvia used for? It is typically prescribed to support bone health and prevent bone loss.

Side Effects

Common effects of Atelvia 30.1 mg may include gastrointestinal discomfort, such as nausea or stomach pain. Some users might experience heartburn or difficulty swallowing. These effects are generally mild and temporary, but if they persist or worsen, it is important to consult a healthcare provider.

Precautions & Warnings

Atelvia 30.1 mg should be taken with a full glass of water while standing or sitting upright. It is important to avoid lying down for at least 30 minutes after taking this medication to prevent irritation of the esophagus. Individuals with certain medical conditions, such as low calcium levels or difficulty swallowing, should discuss their health status with a healthcare provider before starting this medication.

Avoid Interactions

Atelvia 30.1 mg may interact with certain medications, including antacids, calcium supplements, and other oral medications. It is advisable to take this medication at least 30 minutes before other oral medications or supplements. Additionally, food and beverages containing calcium, magnesium, or aluminum may reduce the effectiveness of Atelvia. Always inform your healthcare provider about all medications and supplements you are taking.

Frequently Asked Questions

Atelvia 30.1 mg is used to support bone health and treat conditions related to bone loss, such as osteoporosis.

Atelvia 30.1 mg should be taken with a full glass of water while standing or sitting upright, and you should avoid lying down for at least 30 minutes afterward.

Common side effects may include gastrointestinal discomfort, nausea, stomach pain, heartburn, and difficulty swallowing.

Atelvia 30.1 mg may interact with certain medications, so it is important to consult your healthcare provider before combining it with other treatments.

Individuals with certain medical conditions, such as low calcium levels or difficulty swallowing, should discuss their health status with a healthcare provider before starting Atelvia 30.1 mg.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.